Evommune, Inc. (EVMN)
12.01
-0.47
(-3.77%)
USD |
NYSE |
Sep 03, 16:00
12.01
0.00 (0.00%)
After-Hours: 20:00
Evommune Net Income (Annual) : -68.87M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -68.87M |
| December 31, 2024 | -66.81M |
| Date | Value |
|---|---|
| December 31, 2023 | -34.05M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| MapLight Therapeutics, Inc. | -161.15M |
| Mineralys Therapeutics, Inc. | -154.65M |
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Oncolytics Biotech, Inc. | -28.76M |
| Sangamo Therapeutics, Inc. | -122.93M |